Sort
27,075 grants matching “cholesterol”
Mechanism Of Cholesterol Accumulation In Human Atherosclerosis
$1,031,921Howard S Kruth · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
Mediterranean Dietary Intervention in Pediatric Hyperlipidemia
$1,031,323Marguerite Engler · National Institute Of Nursing Research · ZIA · FY2013 · NR
Development of recombinant Lecithin Cholesterol Acyltransferase as a therapeutic
$1,030,857Alan Remaley · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Use Of Animal Models To Study Genes That Modulate Atherosclerosis
$1,030,857Alan Remaley · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Development of Apo Mimetic Peptides for the Treatment Cardiovascular Disease
$1,030,857Alan Remaley · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Manganese-based Contrast Agent for Cardiovascular MRI
$1,030,766Vera Hoffman · Reveal Pharma · R44 · FY2024 · HL
Proof of Extended Absorption of Liothyronine from PolyZincLiothyronine (PZL) inHumans
$1,029,452Thomas Piccariello · Synthonics, Inc. · R44 · FY2020 · DK
Acute Hepatitis C Infection in Young Injectors
$1,027,825Kimberly Page · University Of California, San Francisco · R01 · FY2012 · DA
Cell Cholesterol Efflux and HDL Formation
$1,027,398University Of California San Francisco · P01 · FY2003 · HL
Effects of Standardized Aerobic Exercise-Training on Neurocognitive and Neurodege
$1,027,189Thomas O Obisesan · Howard University · R01 · FY2009 · AG
Inflammatory Mechanisms and Treatment Strategies for Atherosclerosis in HIV
$1,026,954Steven Kyle Grinspoon · Massachusetts General Hospital · R01 · FY2011 · HL
Manganese-based Contrast Agent for Cardiovascular MRI
$1,026,595Vera Hoffman · Reveal Pharma · R44 · FY2023 · HL
Functional And Genetic Analyses Of Mouse Deafness Mutants
$1,025,667Konrad Noben-Trauth · National Institute On Deafness And Other Communication Disorders · ZIA · FY2010 · DC
Pre- and Peri-natal Predictors of Childhood Obesity
$1,024,170Emily Oken · Harvard Pilgrim Health Care, Inc. · R01 · FY2017 · HD
Mechanism Of Cholesterol Accumulation In Human Atherosclerosis
$1,024,140Howard S Kruth · National Heart, Lung, And Blood Institute · ZIA · FY2009 · HL
MOLECULAR MECHANISMS OF CHOLESTEROL ABSORPTION
$1,023,964University Of Cincinnati · P01 · FY2002 · DK
Treatment of Acute Coronary Syndromes with Recombinant LCAT Infusion
$1,022,830Brian Robert Krause · Alphacore Pharma, Llc · R44 · FY2010 · HL
Identifying new strategies for prevention of cardiovascular complications of diabetes
$1,022,830Karin E. Bornfeldt · University Of Washington · R35 · FY2023 · HL
Preterm Delivery and Maternal Cardiovascular Disease Risk
$1,022,326Claudia B. Holzman · Michigan State University · R01 · FY2012 · HL
Preservation of Proteomic Stability and Promotion of Protein Lipidation by HSF1
$1,021,968Chengkai Dai · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Inhibition of hepatitis C by RNA-based therapeutics
$1,021,558Brian H. Johnston · Somagenics, Inc. · R44 · FY2007 · AI
Use Of Animal Models To Study Genes That Modulate Atherosclerosis
$1,019,615Alan Remaley · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL
Metabolic Effects of Newer Antipsychotics in Older Pts
$1,018,511Dilip V Jeste · Veterans Medical Research Fdn/San Diego · R01 · FY2009 · MH
Identifying new strategies for prevention of cardiovascular complications of diabetes
$1,017,915Karin E. Bornfeldt · University Of Washington · R35 · FY2021 · HL
Non-coding RNA regulation of cholesterol homeostasis and atherosclerosis
$1,017,000Kathryn J Moore · New York University School Of Medicine · R35 · FY2022 · HL